Detalhe da pesquisa
1.
Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis.
Dig Dis Sci;
68(2): 514-520, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35989386
2.
Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome.
Ann Hepatol;
28(4): 101105, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37088418
3.
Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease.
Ann Hepatol;
20: 100253, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32949785
4.
Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group.
Eur J Intern Med;
116: 43-50, 2023 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37302951
5.
Fibrates for the Treatment of Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid: An Exploratory Study.
Front Pharmacol;
12: 818089, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35126149
6.
Epidemiologia das hepatites virais por classificação etiológica / Epidemiology of viral hepatitis by etiological classification
Rev. Soc. Bras. Clín. Méd;
16(4): 227-231, out.-dez. 2018. tab., graf.
Artigo
em Português
| LILACS
| ID: biblio-1025919
7.
Tripla infecção com HTLV-1, leishmaniose visceral e estrongiloidíase complicada por pancreatite aguda / Triple infection with HTLV-1, visceral leishmaniasis and strongyloidiasis complicated by acute pancreatitis
GED gastroenterol. endosc. dig;
35(3): 96-100, jul.-set. 2016. ilustrado
Artigo
em Português
| LILACS
| ID: biblio-2442